Event Details

ASCO Annual Meeting: Preliminary Results From CLASSICAL-Lung, a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer (NSCLC)

06/01/19 at 9:00 AM EDT
Event Details
Title
ASCO Annual Meeting: Preliminary Results From CLASSICAL-Lung, a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
Date / Time
06/01/19 at 9:00 AM EDT